Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer

British Journal of Cancer

Volumn 73, Issue 10, 1996, Pages 1220-1226

  Beckmann, M W ^a   Picard, F ^a   An, H X ^b   Van Roeyen, Crc ^a   Dominik, S I ^a   Mosny, D S ^a   Schnurch H G ^a   Bender, H G ^a   Niederacher, D ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

BRCA1; BRCA2; Breast cancer; Fluorescent polymerase chain reaction; Loss of heterozygosity

Indexed keywords

DNA MINISATELLITE; MARKER; TUMOR MARKER;

ARTICLE; BREAST CANCER; DNA POLYMORPHISM; FLUORESCENCE; GENE; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0029894211     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.234     Document Type: Article

References (37)

1. ALBERTSEN HM, SMITH SA, MAZOYER S, FUJIMOTO E, STEVENS J, WILLIAMS B, RODRIGUEZ P, CROPP CS, SLIJEPCEVIC P, CARLSON M, ROBERTSON M, BRADLEY P, LAWRENCE E, HARRINGTON T, MEI SHENG Z, HOOPES R, STERNBERG N, BROTHMAN A, CALLAHAN R, PONDER BAJ AND WHITE R. (1994). A physical map and candidate genes in the BRCA1 region on chromosome 17q12-21. Nature Genet., 7, 472-479.
2. ANDERSEN TI, GAUSTAD A, OTTESTAD L, FARRANTS GW, NESLAND JM, TVEIT KM AND BÖRRESEN AL. (1992). Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas. Genes Chrom. Cancer, 4, 113-121.
3. BECKMANN MW, TUTSCHEK B, KRÜGER KH, NIEDERACHER D, RISSE BC, RUPPERT C, SCHNÜRCH HG AND BENDER H. (1993). Comparison of the biochemical and immunohistochemical detection of the epidermal growth factor receptor (EGF-R) in breast tumor samples. Int. J. Oncol., 3, 389-397.
4. BLACK DM. (1994). The genetics of breast cancer. Eur. J. Cancer, 30A, 1957-1961.
5. BOYD J. (1995). BRCA1: more than a heriditary breast cancer gene? Nature Genet., 9, 335-336.
6. CHEN LC, KURISU W, LJUNG BM, GOLDMAN ES, MOORE II D AND SMITH HS. (1992). Heterogeneity for allelic loss in human breast cancer. J. Natl Cancer Inst., 84, 506-510.
7. COLLINS N, MCMANUS R, WOOSTER R, MANGION J, SEAL S, LAKHANI SR, ORMISTON W, DALY PA, FORD D, EASTON DF AND STRATTON MR. (1995). Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene, 10, 1673-1675.
8. CROPP CS, CHAMPEME MH, LIDEREAU R AND CALLAHAN R. (1993). Identification of three regions on chromosome 17q in primary human breast carcinomas which are frequently deleted. Cancer Res., 53, 5617-5619.
9. DENG G, CHEN LC, SCHOTT DR, THOR A, BHARGAVA V, LJUNG BM, CHEW K AND SMITH HS. (1994). Loss of heterozygosity and p53 gene mutations in breast cancer. Cancer Res., 54, 499-505.
10. DEVILEE P AND CORNELISSE CJ. (1994). Somatic genetic changes in human breast cancer. Biochim. Biophys. Acta, 1198, 113-130.
11. EASTON DF, BISHOP DT, FORD D, CROCKFORD GP AND THE BREAST CANCER LINKAGE CONSORTIUM. (1993). Genetic linkage analysis in familial and ovarian cancer: results in 214 families. Am. J. Hum. Genet., 52, 678-701.
12. EL-ASHRY D AND LIPPMAN ME. (1994). Molecular Biology of breast carcinoma. World J. Surg., 18, 12-20.
13. FORD D, EASTON DF, BISHOP DT, NAROD SA, GOLDGAR DE AND THE BREAST CANCER LINKAGE CONSORTIUM. (1994). Risks of cancer in BRCA1-mutation carriers. Lancet, 343, 692-695.
14. FUTREAL PA, SÖDERQUIST P, MARKS JR, IGLEHART JD, COCHRAN C, BARRETT JC AND WISEMAN R. (1992). Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphismus. Cancer Res., 52, 2624-2627.
15. FUTREAL PA, LIU Q, SHATTUCK-EIDENS D, COCHRAN C, HARSHMAN K, TAVTIGIAN S, BENNETT LM, HAUGEN-STRANO A, SWENSEN J, MIKI Y, EDDINGTON K, MCCLURE M, FRYE C, WEAVER-FELDHAUS J, DING W, GHOLAMI Z, SÖDERQUIST P, TERRY L, JHANWAR S, BERCHUCK A, IGLEHART JD, MARKS J, BALLINGER DG, BARRETT JC, SKOLNICK MH, KAMB A AND WISEMAN R. (1994). BRCA1 mutations in primary breast cancer and ovarian carcinomas. Science, 266, 120-122.
16. HALL JM, LEE MK, NEWMAN B, MORROW JE, ANDERSON LA, HUEY B AND KING MC. (1990). Linkage of early-onset familial breast cancer to chromosome 17q21. Science, 250, 1684-1689.
17. HALL JM, FRIEDMAN L, GUNTHER C, LEE MK, WEBER JL, BLACK DM AND KING MC. (1992). Closing in on a breast cancer gene on chromosome 17q. Am. J. Hum. Genet., 50, 1235-1242.
18. HOGERVORST FBL, CORNELIS RS, BOUT M, VAN VLIET M, OSTERWIJK JC, OLMER R, BAKKER B, KLIJN JGM, VASEN HFA, MEIJERS-HEIJBOER H, MENKO FH, CORNELISSE CJ, DEN DUNNEN JT, DEVILEE P AND VAN OMMEN GJB. (1995). Rapid detection of BRCA1 mutations by the protein truncation test. Nature Genet., 10, 208-212.
19. HOSKING L, TROWSDALE J, NICOLAI H, SOLOMON E, FOULKES W, STAMP G, SIGNER E AND JEFFREYS A. (1995). A somatic BRCA1 mutation in an ovarian tumour. Nature Genet., 9, 343-344.
20. JACQUEMIER J, EISINGER F, BIRNBAUM D AND SOBOL H. (1995). Histoprognostic grade in BRCA1-associated breast cancer. Lancet, 345, 1503.
21. KIRCHWEGER R, ZEILINGER R, SCHNEEBERGER C, SPEISER P, LOUASON G AND THEILLET G. (1994). Patterns of allele losses suggest the existence of five distinct regions of LOH on chromosome 17 in breast cancer. Int. J. Cancer, 56, 193-199.
22. KNYAZEV PG, IMYANITOV EN, CHERNITSA OI AND NIKIFOROVA IF. (1993). Loss of heterozygosity at 17p is associated with Her-2 amplification and lack of nodal involvement in breast cancer. Int. J. Cancer, 53, 11-16.
23. LALLE P, DE LATOUR M, RIO P AND BIGNON YJ. (1994). Detection of allelic losses on 17q12-q21 chromosomal region in benign lesions and malignant tumors occurring in a familial context. Oncogene, 9, 437-442.
24. LIU ET, HE M AND RAJGOPAL U. (1993). Differential polymerase chain reaction in the analysis of gene dosage. Semin. Cancer Biol., 4, 47-58.
25. LUBIN MB, ELASHOFF JD, WANG SJ, ROTTER JI AND TARADA H. (1991). Precise gene dosage determination by polymerase chain reaction: theory, methodology, and statistical approach. Mol. Cell. Probes, 5, 307-317.
26. LYNCH HT, LYNCH J, CONWAY T, WATSON P, FEUNTEUN J, LENOIR G, NAROD S AND FITZGIBBONS R. (1994). Heriditary breast cancer and family cancer syndroms. World J. Surg., 18, 21-31.
27. MERAJVER SD, PHAM TM, CADUFF RF, CHEN M, POY EL, COONEY KA, WEBER BL, COLLINS ES, JOHNSTON C AND FRANK TS. (1995). Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nature Genet., 9, 439-443.
28. MIKI Y, SWENSEN J, SHATTUCK-EIDENS D, FUTREAL PA, HARSHMAN K, TAVTIGIAN S, LIU Q, COCHRAN C, BENNETT LM, DING W, BELL R, ROSENTHAL J, HUSSEY C, TRAN T, MCCLURE M, FRYE C, HATTIER T, PHELPS R, HAUGEN-STRANO A, KATCHER H, YAKUMO K, GHOLAMI Z, SHAFFER D, STONE S, BAYER S, WRAY C, BODGEN R, DAYANANTH P, WARD J, TONIN P, NAROD S, BRISTOW PK, NORRIS FH, HELVERING L, MORRISSON P, ROSTECK P, LAI M, BARRETT JC, LEWIS C, NEUHAUSEN S, CANNON-ALBRIGHT L, GOLDGAR D, WISEMAN R, KAMB A AND SKOLNICK MH. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66-71.
29. NIEDERACHER D, AN HX, PICARD F, VAN ROEYEN CNC, MOSNY DS, SCHNÜRCH HG, BENDER HG AND BECKMAN MW. (1995). Frequent allelic loss of chromosome 17 in sporadic breast cancer detected by fluorescent labelled microsatellite analysis and automated DNA technology. Cancer Res., (submitted).
30. SAVITSKY K, BAR-SHIRA A, GILAD S, ROTMAN G, ZIV Y, VANAGAITE L, TAGLE DA, SMITH S, UZIEL T, SFEZ S, ASHKENAZI M, PECKER I, FRYDMAN M, HARNIK R, PATANJALE SR, SIMMONS A, CLINES GA, SARTIEL A, GATTI RA, CHESSA L, SANAL O, LAVIN MF, JASPERS NGJ, TAYLOR AMR, ARLETT CF, MIKI T, WEISSMAN SM, LOVETT M, COLLINS FS AND SHILOH Y. (1995). A single ataxia telangiectasia gene with a product similar to PI-2 kinase. Science, 286, 1749-1753.
31. SATO T, TANIGAMI A, YAMAKAWA K, AKIYAMA F, KASUMI F, SAKAMOTO G AND NAKAMURA Y. (1990). Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res., 50, 7184-7189.
32. SHATTUCK-EIDENS D, MCCLURE M, SIMARD J, LABRIE F, NAROD S, COUCH F, HOSKINS K, WEBER B, CASTILLA L, ERDOS M, BRODY L, FRIEDMAN L, OSTERMEYER H, SZABO C, KING MC, JHANWAR S, OFFIT K, NORTON L. GILEWSKI T, LUBIN M, OSBORNE M, BLACK D, BOYD M, STEEL M, INGLES S, HAILE R, LINDBLOM A, OLSSON H, BORG A, BISHOP T, SOLOMON E, RADICE P, SPATTI G, GAYTHER S, PONDER B, WARREN W, STRATTON M, LIU Q, FUJIMURA F, LEWIS C, SKOLNICK MH AND GOLDGAR DE. (1995). A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. JAMA, 273, 535-541.
33. SHIBATA D. (1994). Extraction of DNA from paraffin-embedded tissue for analysis by polymerase chain reaction: new tricks from an old friend. Hum. Pathol., 25, 561-563.
34. STRAUSS WM. (1994). Unit 2.2: Preparation of genomic DNA from mammalian tissue. In: Current Protocols in Molecular Biology. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA and Struhl K, eds. Vol. 1, Chichester: John Wiley.
35. THOMPSON ME, JENSEN RA, OBERMILLER PS, PAGE DL AND HOLT JT. (1995). Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nature Genet., 9, 444-450.
36. WOOSTER R, NEUHAUSEN SL, MANGION J, QUIRK Y, FORD D, COLLINS N, NGUYEN K, SEAL S, TRAN T, AVERILL D, FIELDS P, MARSHALL G, NAROD S, LENOIR GM, LYNCH H, FEUNTEUN J, DEVILEE P, CORNELISSE CJ, MENKO FH, DALY PA, ORMISTON W, MCMANUS R, PYE C, LEWIS CM, CANNON-ALBRIGHT LA, PETO J, PONDER BAJ, SKOLNICK MH, EASTON DF, GOLDGAR DE AND STRATTON MR. (1994). Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12 - 13. Science, 265, 2088-2090.
37. WOOSTER R, BIGNELL G, LANCASTER J, SWIFT S, SEAL S, MANGION J, COLLINS N, GREGORY S, GUMBS C, MICKLEM G, BARFOOT R, HAMOUDI R, PANTEL S, RICE C, BIGGS P, HASHIM Y, SMITH A, CONNOR F, ARASON A, GUDMUNDSSON J, FICENEC D, KELSELL D, FORD D, TONIN P, BISHOP DT, SPURR NK, PONDER BAJ, EELES R, PETO J, DEVILEE P, CORNELISSE C, LYNCH H, NAROD S, LENOIR G, EGILSSON V, BARKADOTTIR RB, EASTON DF, BENTLEY DR, FUTREAL PA, ASHWORTH A AND STRATTON MR. (1995). Identification of the breast cancer gene BRCA2. Nature, 378, 789-792.